Senseonics (SENS)
(Delayed Data from AMEX)
$0.35 USD
+0.02 (7.31%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $0.36 +0.01 (1.69%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth D Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$0.35 USD
+0.02 (7.31%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $0.36 +0.01 (1.69%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth D Momentum D VGM
Zacks News
Senseonics Holdings (SENS) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Senseonics (SENS) delivered earnings and revenue surprises of 0% and 16.15%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Syneos Health (SYNH) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Syneos Health (SYNH) delivered earnings and revenue surprises of 5.21% and 0.78%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Senseonics Holdings (SENS) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Senseonics (SENS) delivered earnings and revenue surprises of 133.33% and 0.20%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
AllScripts Healthcare (MDRX) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
AllScripts (MDRX) delivered earnings and revenue surprises of 154.84% and 0.08%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Fullgent Genetics (FLGT) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Fullgent Genetics (FLGT) delivered earnings and revenue surprises of 25.56% and 31.01%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Do Options Traders Know Something About Senseonics (SENS) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to for Senseonics (SENS) stock based on the movements in the options market lately.
Are Options Traders Betting on a Big Move in Senseonics (SENS) Stock?
by Zacks Equity Research
Investors need to pay close attention to Senseonics (SENS) stock based on the movements in the options market lately.
Senseonics Holdings (SENS) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
Senseonics (SENS) delivered earnings and revenue surprises of 57.14% and -4.02%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Senseonics Holdings (SENS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Senseonics (SENS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Implied Volatility Surging for Senseonics (SENS) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Senseonics (SENS) stock based on the movements in the options market lately.
Implied Volatility Surging for Senseonics Holdings (SENS) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Senseonics Holdings (SENS) stock based on the movements in the options market lately.
Senseonics Holdings (SENS) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Senseonics (SENS) delivered earnings and revenue surprises of -150.00% and 9.74%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Senseonics Holdings (SENS) Flat As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Senseonics Holdings (SENS) closed at $3.03, marking no change from the previous day.
What's in Store for Senseonics Holdings' (SENS) Q2 Earnings?
by Zacks Equity Research
Senseonics Holdings' (SENS) second-quarter results are likely to gain from higher sales outside the United States.
Senseonics Holdings (SENS) Flat As Market Sinks: What You Should Know
by Zacks Equity Research
In the latest trading session, Senseonics Holdings (SENS) closed at $3.05, marking no change from the previous day.
Is the Options Market Predicting a Spike in Senseonics (SENS) Stock?
by Zacks Equity Research
Investors need to pay close attention to Senseonics (SENS) stock based on the movements in the options market lately.
Company News for Jun 7, 2021
by Zacks Equity Research
Companies in the news are: REGN, CHRS, SENS, CGEM
Do Options Traders Know Something About Senseonics (SENS) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Senseonics (SENS) stock based on the movements in the options market lately.
Senseonics Holdings (SENS) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Senseonics (SENS) delivered earnings and revenue surprises of 33.33% and 5.41%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Will Senseonics Holdings (SENS) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
Senseonics (SENS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Implied Volatility Surging for Senseonics (SENS) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Senseonics (SENS) stock based on the movements in the options market lately.
Senseonics Holdings (SENS) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Senseonics (SENS) delivered earnings and revenue surprises of -9.09% and 12.72%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Are Options Traders Betting on a Big Move in Senseonics (SENS) Stock?
by Zacks Equity Research
Investors need to pay close attention to Senseonics (SENS) stock based on the movements in the options market lately.
Senseonics (SENS) Enters Overbought Territory
by Zacks Equity Research
Senseonics Holdings (SENS) has moved higher as of late, but there could definitely be trouble on the horizon for this company.
Are Options Traders Betting on a Big Move in Senseonics Holdings (SENS) Stock?
by Zacks Equity Research
Investors need to pay close attention to Senseonics Holdings (SENS) stock based on the movements in the options market lately.